12 Jul 2024 --- Cargill’s EpiCor postbiotic helped reduce cold and flu symptoms, sore throat, muscle aches and pains and reduced the need for medication. The children (ages 4–12) participating in a clinical trial received a daily gummy supplement with 500 mg of the postbiotic. Cargill partnered with clinical research company KGK Science to conduct the study, which was completed during the “traditional cold and flu season” from September 2022 to April 2023. According to the researchers, children are at a high risk of acquiring cold or flu infections, while safe and productive mitigating regimens are lacking.
